BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Ischemia
,
Kidney
,
Laser capture microdissection
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antitumour
Summary
General Info
Curated Studies
Most Correlated Studies
Psoriasis lesion response to etanercept treatment
Yeast response to the DNA damaging beta-lapachone
Explore Curated Studies Results
Literature
Most Relevant Literature
The antitumour effects of caloric restriction are mediated by the gut microbiome.
Mechano-boosting nanomedicine antitumour efficacy by blocking the reticuloendothelial system with st…
Dynamics of an Antitumour Model with Pulsed Radioimmunotherapy.
Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Antitumour metastasis and the antiangiogenic and antitumour effects of a Eimeria stiedae soluble pro…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Adva…
177Lu-HTK03170 in mCRPC With PSMA Positive Disease
Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse
An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ